Abrass C K, O'Connor S W, Scarpace P J, Abrass I B
J Immunol. 1985 Aug;135(2):1338-41.
The beta-adrenergic receptor was characterized on BCG-activated rat peritoneal macrophage membranes by radio-ligand binding studies. Saturable binding with [125I]iodocyanopindolol (125I-ICYP) was demonstrated. With Scatchard analysis, rat macrophages demonstrate approximately 1000 receptors per cell with a Kd of 5 X 10(-11) M for 125I-ICYP. Competition curves with (-) and (+) propranolol at concentrations below 10(-6) M confirmed stereospecificity. The potency of various ligands to compete for 125I-ICYP binding sites followed the order: propranolol greater than isoproterenol greater than epinephrine greater than norepinephrine with apparent Kd of 2.0 X 10(-9), 3.9 X 10(-7), 1.0 X 10(-5), and 2.5 X 10(-5) M, respectively. Isoproterenol-stimulated adenylate cyclase activity was two-fold above basal activity. The potential physiologic significance of a beta-adrenergic receptor on rat peritoneal macrophages was suggested by a dose-dependent decrease in phagocytosis of soluble, model immune complexes (aggregated gamma-globulin) by macrophages incubated with metaproterenol. We conclude that the rat macrophage has a beta-adrenergic receptor and that catecholamines may thereby modulate macrophage function.
通过放射性配体结合研究,在卡介苗激活的大鼠腹膜巨噬细胞膜上对β-肾上腺素能受体进行了表征。证明了与[125I]碘氰吲哚洛尔(125I-ICYP)的可饱和结合。通过Scatchard分析,大鼠巨噬细胞每个细胞显示约1000个受体,对125I-ICYP的解离常数(Kd)为5×10^(-11) M。浓度低于10^(-6) M的(-)和(+)普萘洛尔的竞争曲线证实了立体特异性。各种配体竞争125I-ICYP结合位点的效力顺序为:普萘洛尔>异丙肾上腺素>肾上腺素>去甲肾上腺素,其表观解离常数分别为2.0×10^(-9)、3.9×10^(-7)、1.0×10^(-5)和2.5×10^(-5) M。异丙肾上腺素刺激的腺苷酸环化酶活性比基础活性高两倍。与间羟异丙肾上腺素孵育的巨噬细胞对可溶性模型免疫复合物(聚集的γ-球蛋白)的吞噬作用呈剂量依赖性降低,提示大鼠腹膜巨噬细胞上β-肾上腺素能受体具有潜在的生理意义。我们得出结论,大鼠巨噬细胞具有β-肾上腺素能受体,儿茶酚胺可能由此调节巨噬细胞功能。